Literature DB >> 36187372

Pneumocystis jiroveci pneumonia prophylaxis in patients with autoimmune hepatitis.

Patrick Stauffer1, Joseph Ahn2.   

Abstract

Content available: Author Interview and Audio Recording.
© 2022 American Association for the Study of Liver Diseases.

Entities:  

Year:  2022        PMID： 36187372      PMCID： PMC9512474          DOI： 10.1002/cld.1233

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  21 in total

1.  British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis.

Authors:  Dermot Gleeson; Michael A Heneghan
Journal:  Gut       Date:  2011-07-13       Impact factor: 23.059

Review 2.  Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.

Authors:  Anat Stern; Hefziba Green; Mical Paul; Liat Vidal; Leonard Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2014-10-01

3.  Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression.

Authors:  Thomas G Cotter; Nicola Gathaiya; Jelena Catania; Edward V Loftus; William J Tremaine; Larry M Baddour; W Scott Harmsen; Alan R Zinsmeister; William J Sandborn; Andrew H Limper; Darrell S Pardi
Journal:  Clin Gastroenterol Hepatol       Date:  2016-12-21       Impact factor: 11.382

Review 4.  Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014.

Authors:  L Cooley; C Dendle; J Wolf; B W Teh; S C Chen; C Boutlis; K A Thursky
Journal:  Intern Med J       Date:  2014-12       Impact factor: 2.048

Review 5.  Infection Risk and Safety of Corticosteroid Use.

Authors:  Jameel Youssef; Shannon A Novosad; Kevin L Winthrop
Journal:  Rheum Dis Clin North Am       Date:  2015-10-24       Impact factor: 2.670

6.  Incidence of Pneumocystis jiroveci pneumonia among groups at risk in HIV-negative patients.

Authors:  Pierre Fillatre; Olivier Decaux; Stéphane Jouneau; Matthieu Revest; Arnaud Gacouin; Florence Robert-Gangneux; Annie Fresnel; Claude Guiguen; Yves Le Tulzo; Patrick Jégo; Pierre Tattevin
Journal:  Am J Med       Date:  2014-07-21       Impact factor: 4.965

7.  Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases.

Authors:  Cara L Mack; David Adams; David N Assis; Nanda Kerkar; Michael P Manns; Marlyn J Mayo; John M Vierling; Mouaz Alsawas; Mohammad H Murad; Albert J Czaja
Journal:  Hepatology       Date:  2020-05-12       Impact factor: 17.425

8.  Epidemiological and clinical characteristics of immunocompromised patients infected with Pneumocystis jirovecii in a twelve-year retrospective study from Norway.

Authors:  Stine Grønseth; Tormod Rogne; Raisa Hannula; Bjørn Olav Åsvold; Jan Egil Afset; Jan Kristian Damås
Journal:  BMC Infect Dis       Date:  2021-07-07       Impact factor: 3.090

9.  Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection.

Authors:  Xavier Monnet; Emmanuelle Vidal-Petiot; David Osman; Olfa Hamzaoui; Antoine Durrbach; Cécile Goujard; Corinne Miceli; Patrice Bourée; Christian Richard
Journal:  Crit Care       Date:  2008-01-25       Impact factor: 9.097

10.  Is Routine Prophylaxis Against Pneumocystis jirovecii Needed in Liver Transplantation? A Retrospective Single-Centre Experience and Current Prophylaxis Strategies in Spain.

Authors:  José Ignacio Fortea; Antonio Cuadrado; Ángela Puente; Paloma Álvarez Fernández; Patricia Huelin; Carmen Álvarez Tato; Inés García Carrera; Marina Cobreros; María Luisa Cagigal Cobo; Jorge Calvo Montes; Carlos Ruiz de Alegría Puig; Juan Carlos Rodríguez SanJuán; Federico José Castillo Suescun; Roberto Fernández Santiago; Juan Andrés Echeverri Cifuentes; Fernando Casafont; Javier Crespo; Emilio Fábrega
Journal:  J Clin Med       Date:  2020-11-06       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.